4
Changes in Ownership
C4 Therapeutics, Inc. Filed Acc 0001209191-22-032508
President & CEO acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hirsch Andrew President & CEO | 2022-05-25 | Option exercise | +12,500 | 22,500 | D | ||
| Derivatives | |||||||
| Hirsch Andrew President & CEO | 2022-05-25 | Option exercise · Performance Restricted Stock Units | −12,500 | 75,000 | D | ||
Loading xslF345X03/doc4.xml…